InvestorsHub Logo
Followers 16
Posts 1771
Boards Moderated 0
Alias Born 09/05/2017

Re: None

Tuesday, 12/06/2022 12:45:35 PM

Tuesday, December 06, 2022 12:45:35 PM

Post# of 459734
BTW - Lecanemab was published in a peer reviewed article within just a month or two of initial results being PR'd.
That's Missling's bogey.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News